The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Precision Cancer Therapies-Global Market Insights and Sales Trends 2024
Synopsis
Precision cancer therapies is an evolving approach to cancer care that aims to leverage new knowledge regarding the pathogenesis of cancer to more precisely target therapy.
The global Precision Cancer Therapies market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Precision Cancer Therapies in various end use industries. The expanding demands from the Hospitals, Diagnostic Centers, Oncology Clinics and Research Institutes, are propelling Precision Cancer Therapies market. Hormone Therapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Immunotherapies segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Precision Cancer Therapies, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Precision Cancer Therapies market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Precision Cancer Therapies market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Precision Cancer Therapies sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Precision Cancer Therapies covered in this report include Abbott Laboratories, Bayer HealthCare, GlaxoSmithKline, OncoGenex Pharmaceuticals, Hospira, Boehringer Ingelheim, AstraZeneca and Aveo Pharmaceuticals, etc.
The global Precision Cancer Therapies market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Bayer HealthCare
GlaxoSmithKline
OncoGenex Pharmaceuticals
Hospira
Boehringer Ingelheim
AstraZeneca
Aveo Pharmaceuticals
Global Precision Cancer Therapies market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Precision Cancer Therapies market, Segment by Type:
Hormone Therapy
Immunotherapies
Targeted Therapy
Monoclonal Antibody Therapy
Gene Therapy
Global Precision Cancer Therapies market, by Application
Hospitals
Diagnostic Centers
Oncology Clinics
Research Institutes
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Precision Cancer Therapies companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Precision cancer therapies is an evolving approach to cancer care that aims to leverage new knowledge regarding the pathogenesis of cancer to more precisely target therapy.
The global Precision Cancer Therapies market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Precision Cancer Therapies in various end use industries. The expanding demands from the Hospitals, Diagnostic Centers, Oncology Clinics and Research Institutes, are propelling Precision Cancer Therapies market. Hormone Therapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Immunotherapies segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Precision Cancer Therapies, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Precision Cancer Therapies market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Precision Cancer Therapies market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Precision Cancer Therapies sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Precision Cancer Therapies covered in this report include Abbott Laboratories, Bayer HealthCare, GlaxoSmithKline, OncoGenex Pharmaceuticals, Hospira, Boehringer Ingelheim, AstraZeneca and Aveo Pharmaceuticals, etc.
The global Precision Cancer Therapies market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Bayer HealthCare
GlaxoSmithKline
OncoGenex Pharmaceuticals
Hospira
Boehringer Ingelheim
AstraZeneca
Aveo Pharmaceuticals
Global Precision Cancer Therapies market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Precision Cancer Therapies market, Segment by Type:
Hormone Therapy
Immunotherapies
Targeted Therapy
Monoclonal Antibody Therapy
Gene Therapy
Global Precision Cancer Therapies market, by Application
Hospitals
Diagnostic Centers
Oncology Clinics
Research Institutes
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Precision Cancer Therapies companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Precision Cancer Therapies
1.1 Precision Cancer Therapies Market Overview
1.1.1 Precision Cancer Therapies Product Scope
1.1.2 Precision Cancer Therapies Market Status and Outlook
1.2 Global Precision Cancer Therapies Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Precision Cancer Therapies Market Size by Region (2018-2029)
1.4 Global Precision Cancer Therapies Historic Market Size by Region (2018-2023)
1.5 Global Precision Cancer Therapies Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Precision Cancer Therapies Market Size (2018-2029)
1.6.1 North America Precision Cancer Therapies Market Size (2018-2029)
1.6.2 Europe Precision Cancer Therapies Market Size (2018-2029)
1.6.3 Asia-Pacific Precision Cancer Therapies Market Size (2018-2029)
1.6.4 Latin America Precision Cancer Therapies Market Size (2018-2029)
1.6.5 Middle East & Africa Precision Cancer Therapies Market Size (2018-2029)
2 Precision Cancer Therapies Market by Type
2.1 Introduction
2.1.1 Hormone Therapy
2.1.2 Immunotherapies
2.1.3 Targeted Therapy
2.1.4 Monoclonal Antibody Therapy
2.1.5 Gene Therapy
2.2 Global Precision Cancer Therapies Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Precision Cancer Therapies Historic Market Size by Type (2018-2023)
2.2.2 Global Precision Cancer Therapies Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Precision Cancer Therapies Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Precision Cancer Therapies Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Precision Cancer Therapies Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Precision Cancer Therapies Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Precision Cancer Therapies Revenue Breakdown by Type (2018-2029)
3 Precision Cancer Therapies Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Diagnostic Centers
3.1.3 Oncology Clinics
3.1.4 Research Institutes
3.2 Global Precision Cancer Therapies Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Precision Cancer Therapies Historic Market Size by Application (2018-2023)
3.2.2 Global Precision Cancer Therapies Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Precision Cancer Therapies Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Precision Cancer Therapies Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Precision Cancer Therapies Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Precision Cancer Therapies Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Precision Cancer Therapies Revenue Breakdown by Application (2018-2029)
4 Precision Cancer Therapies Competition Analysis by Players
4.1 Global Precision Cancer Therapies Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Precision Cancer Therapies as of 2022)
4.3 Date of Key Players Enter into Precision Cancer Therapies Market
4.4 Global Top Players Precision Cancer Therapies Headquarters and Area Served
4.5 Key Players Precision Cancer Therapies Product Solution and Service
4.6 Competitive Status
4.6.1 Precision Cancer Therapies Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Precision Cancer Therapies Products, Services and Solutions
5.1.4 Abbott Laboratories Precision Cancer Therapies Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Laboratories Recent Developments
5.2 Bayer HealthCare
5.2.1 Bayer HealthCare Profile
5.2.2 Bayer HealthCare Main Business
5.2.3 Bayer HealthCare Precision Cancer Therapies Products, Services and Solutions
5.2.4 Bayer HealthCare Precision Cancer Therapies Revenue (US$ Million) & (2018-2023)
5.2.5 Bayer HealthCare Recent Developments
5.3 GlaxoSmithKline
5.3.1 GlaxoSmithKline Profile
5.3.2 GlaxoSmithKline Main Business
5.3.3 GlaxoSmithKline Precision Cancer Therapies Products, Services and Solutions
5.3.4 GlaxoSmithKline Precision Cancer Therapies Revenue (US$ Million) & (2018-2023)
5.3.5 OncoGenex Pharmaceuticals Recent Developments
5.4 OncoGenex Pharmaceuticals
5.4.1 OncoGenex Pharmaceuticals Profile
5.4.2 OncoGenex Pharmaceuticals Main Business
5.4.3 OncoGenex Pharmaceuticals Precision Cancer Therapies Products, Services and Solutions
5.4.4 OncoGenex Pharmaceuticals Precision Cancer Therapies Revenue (US$ Million) & (2018-2023)
5.4.5 OncoGenex Pharmaceuticals Recent Developments
5.5 Hospira
5.5.1 Hospira Profile
5.5.2 Hospira Main Business
5.5.3 Hospira Precision Cancer Therapies Products, Services and Solutions
5.5.4 Hospira Precision Cancer Therapies Revenue (US$ Million) & (2018-2023)
5.5.5 Hospira Recent Developments
5.6 Boehringer Ingelheim
5.6.1 Boehringer Ingelheim Profile
5.6.2 Boehringer Ingelheim Main Business
5.6.3 Boehringer Ingelheim Precision Cancer Therapies Products, Services and Solutions
5.6.4 Boehringer Ingelheim Precision Cancer Therapies Revenue (US$ Million) & (2018-2023)
5.6.5 Boehringer Ingelheim Recent Developments
5.7 AstraZeneca
5.7.1 AstraZeneca Profile
5.7.2 AstraZeneca Main Business
5.7.3 AstraZeneca Precision Cancer Therapies Products, Services and Solutions
5.7.4 AstraZeneca Precision Cancer Therapies Revenue (US$ Million) & (2018-2023)
5.7.5 AstraZeneca Recent Developments
5.8 Aveo Pharmaceuticals
5.8.1 Aveo Pharmaceuticals Profile
5.8.2 Aveo Pharmaceuticals Main Business
5.8.3 Aveo Pharmaceuticals Precision Cancer Therapies Products, Services and Solutions
5.8.4 Aveo Pharmaceuticals Precision Cancer Therapies Revenue (US$ Million) & (2018-2023)
5.8.5 Aveo Pharmaceuticals Recent Developments
6 North America
6.1 North America Precision Cancer Therapies Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Precision Cancer Therapies Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Precision Cancer Therapies Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Precision Cancer Therapies Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Precision Cancer Therapies Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Precision Cancer Therapies Market Dynamics
11.1 Precision Cancer Therapies Industry Trends
11.2 Precision Cancer Therapies Market Drivers
11.3 Precision Cancer Therapies Market Challenges
11.4 Precision Cancer Therapies Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
